Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $13.4 Million - $16.7 Million
-57,226 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $13,285 - $15,658
60 Added 0.1%
57,226 $14.9 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $879,916 - $1.11 Million
-4,971 Reduced 8.0%
57,166 $12.6 Million
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $11.3 Million - $12.6 Million
62,137 New
62,137 $11.3 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.